Abstract
Technology transfer is the process of transforming basic scientific discoveries into commercial products that can be sold to the public. Historically, the federal government has been the country’s largest funder of basic biomedical research through institutions such as the National Institute of Health (NIH). Private corporations utilize scientific knowledge generated at NIH to design drugs and medical devices that are then marketed to the American public. As a taxpayer funded institution, NIH has a fundamental responsibility to optimize the technology transfer process so that the American public receives the greatest return on its investment in the form of new healthcare products. Various laws passed in the 1980s have set up the technology transfer system to revolve around the dispensation of intellectual property rights. In recent years several prominent critiques of the technology transfer system’s use of intellectual property rights have emerged in academic literature. In order to assess the validity of these critiques I conducted ten oral history interviews with administrators at NIH that are deeply involved in the technology transfer process. This paper will demonstrate that many of the criticisms that are posed in academic literature do not impact research at NIH. However, interviews with officials at NIH indicate that there is still friction in the system that prevents the American public from receiving the maximum return on its investment.Copyright for articles published in this journal is retained by the authors, with first publication rights granted to Vanderbilt Undergraduate Research Journal under a Creative Commons Attribution-Noncommercial-ShareAlike 4.0 International License (linked here). By virtue of their appearance in this open access journal, articles are available for wide dissemination at no cost to readers, with proper attribution (acknowledgment of the work's authorship and initial publication in this journal), in educational and other non-commercial settings. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository, in a journal or publish it in a book), with an acknowledgment of its initial publication in this journal. However, for undergraduates authoring a manuscript under the guidance of a faculty member or research mentor, we strongly encourage the student to discuss with the faculty mentor and the Editor if prior publication in the Vanderbilt Undergraduate Research Journal will constrain future publication efforts in professional journals. To this end, all authors must submit a signed mentor consent form at the time of submission..